LPTX
Price:
$2.81
Market Cap:
$107.52M
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in ...[Read more]
Industry
Biotechnology
IPO Date
2017-01-25
Stock Exchange
NASDAQ
Ticker
LPTX
According to Leap Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.87. This represents a change of 121.91% compared to the average of -1.29 of the last 4 quarters.
The mean historical PE Ratio of Leap Therapeutics, Inc. over the last ten years is -3.05. The current -2.87 PE Ratio has changed 9.31% with respect to the historical average. Over the past ten years (40 quarters), LPTX's PE Ratio was at its highest in in the December 2018 quarter at 4.97. The PE Ratio was at its lowest in in the December 2015 quarter at -19.75.
Average
-3.05
Median
-2.40
Minimum
-6.85
Maximum
-0.77
Discovering the peaks and valleys of Leap Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 531.09%
Maximum Annual PE Ratio = -0.77
Minimum Annual Increase = -86.38%
Minimum Annual PE Ratio = -6.85
Year | PE Ratio | Change |
---|---|---|
2023 | -1.04 | 11.39% |
2022 | -0.93 | -86.38% |
2021 | -6.85 | 41.22% |
2020 | -4.85 | 531.09% |
2019 | -0.77 | -37.12% |
2018 | -1.22 | -36.43% |
2017 | -1.92 | -33.23% |
2016 | -2.88 | -54.67% |
2015 | -6.35 | 73.41% |
2014 | -3.66 | 14.74% |
The current PE Ratio of Leap Therapeutics, Inc. (LPTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.94
5-year avg
-2.89
10-year avg
-3.05
Leap Therapeutics, Inc.’s PE Ratio is less than X4 Pharmaceuticals, Inc. (7.41), greater than Terns Pharmaceuticals, Inc. (-6.06), greater than Day One Biopharmaceuticals, Inc. (-7.39), less than PDS Biotechnology Corporation (-2.64), greater than Inozyme Pharma, Inc. (-3.48), less than eFFECTOR Therapeutics, Inc. (-0.00), less than Elevation Oncology, Inc. (-0.93), greater than Mereo BioPharma Group plc (-18.18), less than Hepion Pharmaceuticals, Inc. (-0.15), less than HOOKIPA Pharma Inc. (-1.22), less than Acumen Pharmaceuticals, Inc. (-2.06),
Company | PE Ratio | Market cap |
---|---|---|
7.41 | $109.78M | |
-6.06 | $549.60M | |
-7.39 | $1.25B | |
-2.64 | $107.88M | |
-3.48 | $312.42M | |
-0.00 | $188.18K | |
-0.93 | $36.94M | |
-18.18 | $664.26M | |
-0.15 | $4.20M | |
-1.22 | $159.50M | |
-2.06 | $133.38M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Leap Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Leap Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Leap Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Leap Therapeutics, Inc. (LPTX)?
What is the highest PE Ratio for Leap Therapeutics, Inc. (LPTX)?
What is the 3-year average PE Ratio for Leap Therapeutics, Inc. (LPTX)?
What is the 5-year average PE Ratio for Leap Therapeutics, Inc. (LPTX)?
How does the current PE Ratio for Leap Therapeutics, Inc. (LPTX) compare to its historical average?